Back to search

Article

Differences in SARS-CoV-2 Specific Humoral and Cellular Immune Responses after Contralateral and Ipsilateral COVID-19 Vaccination

2023-03-07

Abstract excerpt

Background: Individual doses of dual-dose vaccine-regimens are sequentially administered into the deltoid muscle, but little attention has so far been paid to the immunological effects of choosing the ipsilateral or the contralateral side for the second dose.<br><br>Methods: In an observational study, 303 previously naive individuals were recruited, who received the second dose of the COVID-19 vaccine BNT162b2 on...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bee244e2-7cad-5036-82ae-2e74e73f2d5c
DOI
10.2139/ssrn.4380042
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Differences in SARS-CoV-2 Specific Humoral and Cellular Immune Responses after Contralateral and Ipsilateral COVID-19 VaccinationDOI 10.2139/ssrn.4380042
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS‐CoV‐2 vaccinationSemantic proximity
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strainSemantic proximity
Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in EnglandSemantic proximity
Immunogenicity and Reactogenicity of Heterologous and Homologous mRNA-1273 and BNT162b2 Vaccination: A Multicenter Non-Inferiority Randomized TrialSemantic proximity
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general populationSemantic proximity
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot studySemantic proximity
Immunogenicity and efficacy of heterologous ChadOx1/BNT162b2 vaccinationSemantic proximity
Intramuscular COVID-19 Vaccination Elicits SARS-CoV-2 Spike-Specific CD8 <sup> </sup> Tissue-Resident Memory T Cells in the Nasal TissueSemantic proximity
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trialSemantic proximity
Hybrid humoral immune response of Pacific Islanders to BNT162b2 vaccination and Delta/Omicron infection: a cohort studySemantic proximity
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipientsSemantic proximity
Select a neighboring publication to make it the new centre.